Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Covidien
(NY:
COV
)
65.17
USD
-0.04 (-0.06%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,800,414
Open
64.99
Bid (Size)
65.17 (200)
Ask (Size)
65.21 (100)
Prev. Close
65.21
Today's Range
64.57 - 65.62
52wk Range
50.25 - 68.83
Shares Outstanding
473,388,967
Dividend Yield
1.54%
Top News
More News
Covidien Board Approves Separation of Pharmaceuticals Business
May 24, 2013
Covidien plc (NYSE: COV ), a leading global provider of healthcare products, today announced that its board of directors has approved the separation of the Pharmaceuticals business from
Read More
category
Contracts
,
Management
,
Benzinga
, and 4 more.
from
Latest Articles from Benzinga.com
Covidien Board of Directors Approves Separation of Pharmaceuticals Business and Declares Dividend of Mallinckrodt Ordinary Shares
May 24, 2013
from
Business Wire News Releases
More News
Read More
Critical Alerts For Apple, Covidien, Dollar Tree, Chicago Bridge and Iron, and Dunkin Brands By InvestorsObserver
May 23, 2013
from
PR Newswire
Covidien and Mallinckrodt to Present at Deutsche Bank Conference
May 23, 2013
from
Business Wire News Releases
Covidien presenta datos de un ensayo clínico que demuestran que la terapia de ablación endoscópica elimina el tejido precanceroso del esófago y reduce significativamente la progresión de la enfermedad
May 22, 2013
from
Business Wire Spanish
Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression
May 22, 2013
from
Business Wire News Releases
Covidien’s Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians
May 21, 2013
from
Business Wire News Releases
Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims
May 20, 2013
from
Business Wire News Releases
Cramer: Break-Up Could Boost This Stock 19%
May 17, 2013
category
Investing
,
Health Care/Health Care Equipment and Services/Health Care Equipment and Supplies/Health Care Equipm
,
Biotechnology
, and 10 more.
from
CNBC.com News
Cooperman's Omega Advisors Gets Into Gold and Silver ETFs (GLD) (GDX) (SLV) (more...)
May 15, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
